GlaxoSmithKline PLC
GSK
|
|
| |
|
| Trading Volume | 72,085 |
|
|
44.76 - 34.17 |
| Market Cap Full | $ 188.6B |
Quarterly +
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Q1 | -1.1% | 15.7% | 1.2% | -1% |
| Q2 | - | -8.8% | 0.2% | -0.3% |
| Q3 | - | 12.7% | 1.7% | -32.4% |
| Q4 | - | -5.9% | 2.7% | 19.4% |
Monthly +
| J | F | M | A | M | J | J | A | S | O | N | D |
| 2025 | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| -1.1 | - | - | - | - | - | - | - | - | - | - | - |
| 2024 | |||||||||||
| 6.4 | 6.2 | 2.3 | -5.3 | 10.3 | -13.6 | 0.4 | 12.7 | - | - | - | -0.9 |
| 2023 | |||||||||||
| 0.3 | -2.8 | 3.8 | 1.3 | -6.8 | 6.1 | -0.2 | -1.2 | 3.1 | -1.5 | 0.8 | 2.9 |
| 2022 | |||||||||||
| 1.6 | -6.6 | 4.3 | 3.7 | -2.9 | -1 | -3.1 | -23 | -9.4 | 11.6 | 5.3 | 1.6 |
| 2021 | |||||||||||
| 1.4 | -9.8 | 6.2 | 4.6 | 3.8 | 2.7 | 0.8 | 1.5 | -6 | 9.6 | -2.1 | 7.3 |
| 2020 | |||||||||||
| -0 | -14.8 | -5.2 | 11 | -0.4 | -2.7 | -1.2 | -1.8 | -5 | -11.2 | 10.1 | -0.2 |
EPS
| 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|
| Q1 | 0.9 | 0 | 0.6 | 0.8 |
| Q2 | 1 | 0 | 0.8 | 1.1 |
| Q3 | 0.9 | 0 | 0.6 | 0.6 |
| Q4 | 0 | 1.5 | 3 | 0.4 |
| A | 2.78 | 1.5 | 5 | 2.9 |